Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease

Acta Ophthalmol. 2016 Dec;94(8):e820-e821. doi: 10.1111/aos.13147. Epub 2016 Jul 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Biomarkers*
  • Coloring Agents / administration & dosage
  • Drug Combinations
  • Female
  • Fluorescein Angiography
  • Fundus Oculi
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Optical Imaging*
  • Prednisone / therapeutic use
  • Prospective Studies
  • Pulse Therapy, Drug
  • Retinal Pigment Epithelium / pathology*
  • Severity of Illness Index
  • Tomography, Optical Coherence
  • Uveomeningoencephalitic Syndrome / diagnosis*
  • Uveomeningoencephalitic Syndrome / diagnostic imaging
  • Uveomeningoencephalitic Syndrome / drug therapy
  • Young Adult

Substances

  • Biomarkers
  • Coloring Agents
  • Drug Combinations
  • Glucocorticoids
  • Prednisone
  • Methylprednisolone